Financing a company may take many forms. This section offers prudent advice for developing a successful plan to finance the entity.
| Building a Start Up – Critical Steps for Success A Carnegie Mellon University & Morgan Lewis collaboration, this presentation addresses critical areas for start-up success: "Coming to Terms: Negotiating Early Stage Deals." |
| Capitalizing on Corporate Venture Capital and Strategic Investor Relationships How can start-ups and venture capital investors that co-invest with strategic investors better manage their relationships with strategic investors and partners? Morgan Lewis partner E. John Park moderated a panel of some of the leading corporate VCs to address some of these issues and provide some advice to start-up companies and venture capital investors for the VC Taskforce's Corporate Venture Capital special interest group (SIG). |
| Corporate Venturing: Partnering and Investing in Emerging Growth Companies This presentation by Morgan Lewis partner John Park delivers an overview of the corporate venture capital investor experience to an entrepreneur. |
| How to Become Touched by an Angel Authored by multiple Morgan Lewis partners, this article discusses the beginning stages of financing an emerging growth company by focusing on the role and importance of angel investors. |
| How to be Touched by an Angel (Chapter 4), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis) Most funding for startup life sciences ventures comes from a combination of government and quasi-government funding sources such as NIH and private individuals commonly referred to as “angels.” This chapter briefly describes who angels are, why new ventures seek angels, and what angels seek in investments so that your company can be touched by an angel. |
| How to Hunt Money Morgan Lewis partner Jeff Bodle and Steve Bowman of BizClarity authored this article on how entrepreneurs should search for financing. |
| Investor Issues for Later Stage Investments Morgan Lewis partner E. John Park presents to the VC Taskforce on deal trends and terms for investors in the current economy. |
| Preparing a Term Sheet for Your Angel Round Morgan Lewis partner Steve Cohen writes about the importance of doing your homework when preparing a term sheet for initial funding. |
| Preparing a Venture Capital Term Sheet (Chapter 5), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis) The company is growing and you have moved beyond angel financing. It is now time to begin courting venture capitalists. This chapter will help you structure the term sheet or investment by the venture capitalists into the company. |
| Realizing Value from New Venture Spin-Outs (Chapter 2), Emerging Life Sciences Companies Deskbook – Spring 2008 (Morgan Lewis) An alternative way to realize latent value of intellectual property (IP) and potential products that have been “put on the shelf” by an established company is through a new venture spin-out. Profitable businesses can be built with smaller or niche-market biotechnology, pharmaceutical, diagnostic, or device products. Generally, a spin-out involves the transfer of IP by the parent company to a newly created company in exchange for equity. This chapter discusses some key issues to keep in mind in structuring a new venture spin-out. |
| Strategic Investments for Corporate Investors Morgan Lewis partner E. John Park presents to the VC Task Force on key investment subjects for investors when working with entrepreneurs. |
